<DOC>
	<DOCNO>NCT00993967</DOCNO>
	<brief_summary>This Extension study MICONOS main randomise placebo-controlled trial ( NCT00905268 ) , open patient complete main study . The scientific aim extension study monitor safety tolerability idebenone two year patient Friedreich 's Ataxia .</brief_summary>
	<brief_title>Long-Term Safety Tolerability Idebenone Friedreich 's Ataxia Patients ( MICONOS Extension )</brief_title>
	<detailed_description />
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Friedreich Ataxia</mesh_term>
	<mesh_term>Idebenone</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Completion 52 week study SNTIII001 Body weight â‰¥ 25 kg Negative urine pregnancy test Eligibility participate present extension study confirm investigator Safety tolerability issue arise course SNTIII001 opinion investigator preclude treatment idebenone Clinically significant abnormality haematology biochemistry include , limited , elevation great 1.5 time upper limit SGOT , SGPT creatinine Parallel participation another clinical drug trial Pregnancy breastfeeding Abuse drug alcohol</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>FRDA</keyword>
	<keyword>idebenone</keyword>
	<keyword>FRDA disease</keyword>
</DOC>